ARYA Sciences Acquisition Corp III
Status: Closed Deal
U=S
| IPO Proceeds, $M | $149.50M |
|---|---|
| IPO Date | Aug 7, 2020 |
| CEO | Adam Stone |
| Left Lead | Jefferies |
| IPO Cash in Trust | 100.0% |
| SPAC Tenor | 24 months |
| IPO Sector | Healthcare ▶ |
| IPO Geography | Global |
| Target Company | Nautilus Biotechnology |
| Deal Announced | Feb 8, 2021 |
| Deal Size, $M | $905.37M |
| Deal Sector | Healthcare |
| Deal Geography | US/Canada |
| SEC Filings |
www.sec.gov 
|
| Approval Vote | Jun 8, 2021 |
| Amendment Vote | TBD |
| Closing Date | Jun 9, 2021 |
Formerly ARYA
NAUT
| Price | $2.34 |
|---|---|
| Last closing price | $2.27 |
| H/L, today | $2.19 / $2.35 |
| H/L, 52-week | $1.50 / $4.65 |
| Volume, today | 114,811 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in to view structure, cap table, and calendar of events.